Epidermal plasminogen activator is abnormal in cutaneous lesions

Area of Science:

• Dermatology
• Biochemistry
• Immunocytochemistry

Background:

• Plasminogen activator (PA) plays a role in tissue remodeling and degradation.
• Different forms of PA, including tissue-type PA (tPA) and urokinase-type PA (uPA), exist with distinct functions.
• The specific roles of PA in various cutaneous diseases are not fully understood.

Purpose of the Study:

• To investigate the role of plasminogen activator (PA) in the context of cutaneous diseases.
• To differentiate between tPA and uPA activity in normal and lesional skin.
• To immunocytochemically localize tPA in skin lesions of various dermatological conditions.

Main Methods:

• Biochemical assays to measure PA activity in skin samples.
• Immunocytochemical techniques using rabbit antibody specific for tPA.
• Analysis of skin biopsies from patients with pemphigus (benign chronic, vulgaris, foliaceous), bullous pemphigoid, and psoriasis.

Main Results:

• In normal human dermis, tPA is the predominant PA activity.
• In normal human epidermis, uPA is the predominant PA activity.
• In lesional epidermis from patients with various cutaneous diseases, tPA was the predominant PA activity, with a minor contribution from uPA.
• Immunocytochemical localization confirmed elevated tPA in lesions across diverse skin disorders.

Conclusions:

• Tissue plasminogen activator (tPA) is consistently elevated in cutaneous lesions regardless of etiology, pathology, or clinical presentation.
• The findings suggest a significant role for tPA in the pathogenesis of a wide range of skin diseases.
• Further research is warranted to elucidate the specific mechanisms by which tPA contributes to cutaneous disease.